Showing results (121-130 of 302) with videos related to
Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|February 18, 2024
Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IBTeresa Amaral, Lena Nanz, Rudolf Stadler, et al.Biology|December 30, 2025
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and SurvivalAxel Gschwind, Nadja Ballin, Alexander Ott, et al.European Journal of Cancer (Oxford, England : 1990)|March 29, 2026
Diagnostic and prognostic parameters for immune checkpoint inhibitor-related myocarditis: A meta-analysisTobias Lerchner, Florian Buehning, Julia Vogel, et al.American Journal of Clinical Dermatology|May 4, 2023
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based ImmunotherapyEftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas, et al.European Journal of Cancer (Oxford, England : 1990)|September 4, 2020
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter studyMartin Salzmann, Ulrike Leiter, Carmen Loquai, et al.Cancer Immunology, Immunotherapy : CII|October 28, 2020
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitorsJohanna Winter, Max M Lenders, Maximilian Gassenmaier, et al.European Journal of Cancer Care|August 21, 2018
Fear of cancer progression in patients with stage IA malignant melanomaTobias Wagner, Matthias Augustin, Christine Blome, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Incidence of new primary melanomas after diagnosis of stage III and IV melanomaLisa Zimmer, Lauren E Haydu, Alexander M Menzies, et al.Frontiers in Oncology|August 28, 2025
Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutationJulia Forschner, Julia Huynh, Christopher Schroeder, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 12, 2024
Second opinion and self-efficacy in German skin cancer patientsHenner Stege, Sara Schneider, Andrea Forschner, et al.Pageof 31